DOCK8 and hyperinsulinemic hypoglycemia, familial, 4: Given this uncertainty, we advocate aiming for complete donor chimerism in treating DOCK8 deficiency, but suggest aiming at reduced toxicity over myeloablation, especially for patients with pre-existing organ damage.